Sort
53,477 grants matching “addiction”
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
$1,657,600Luis J. Montaner · Wistar Institute · R01 · FY2020 · DA
Stress and Addiction Neuroscience Unit
$1,656,993Leandro Vendruscolo · National Institute On Drug Abuse · ZIA · FY2025 · DA
Center for Adaptive Treatment of Cigarette Addiction
$1,656,333Jed E Rose · Duke University · P50 · FY2019 · DA
22/24 Healthy Brain and Child Development National Consortium
$1,655,882Brittany Rollins Howell · Virginia Polytechnic Inst And St Univ · U01 · FY2024 · DA
Stem cell-loaded microgels to treat discogenic low back pain
$1,655,677Dmitriy Sheyn · Cedars-Sinai Medical Center · R34 · FY2021 · NS
Center for Alcohol Research in Epigenetics
$1,654,973Subhash C Pandey · University Of Illinois At Chicago · P50 · FY2020 · AA
Center for Alcohol Research in Epigenetics
$1,654,973Subhash C Pandey · University Of Illinois At Chicago · P50 · FY2021 · AA
Center for Alcohol Research in Epigenetics
$1,654,973Subhash C Pandey · University Of Illinois At Chicago · P50 · FY2022 · AA
Center for Adaptive Treatment of Cigarette Addiction
$1,654,659Jed E Rose · Duke University · P50 · FY2017 · DA
Center for Adaptive Treatment of Cigarette Addiction
$1,654,659Jed E Rose · Duke University · P50 · FY2018 · DA
Center for Alcohol Research in Epigenetics
$1,654,361Subhash C Pandey · University Of Illinois At Chicago · P50 · FY2023 · AA
Center for Alcohol Research in Epigenetics
$1,654,361Subhash C Pandey · University Of Illinois At Chicago · P50 · FY2024 · AA
Center for Study of Opioid Receptors and Drugs of Abuse
$1,653,580Christopher J Evans · University Of California Los Angeles · P50 · FY2006 · DA
Pennsieve: A scalable and sustainable platform for scientific data integration and analysis
$1,653,476Joost B Wagenaar · University Of Pennsylvania · OT3 · FY2023 · OD
16/24 Healthy Brain and Child Development National Consortium
$1,653,040Nathan A Fox · Univ Of Maryland, College Park · U01 · FY2025 · DA
Development of Orexin-1 Receptor Antagonists for Drug Addiction
$1,652,935Theodore M Kamenecka · Scripps Research Institute, The · P01 · FY2015 · DA
1/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) Consortium
$1,652,884Xiawei Ou · Arkansas Children'S Hospital Res Inst · U01 · FY2023 · DA
Development of Orexin-1 Receptor Antagonists for Drug Addiction
$1,652,504Theodore M Kamenecka · Scripps Research Institute, The · P01 · FY2016 · DA
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
$1,652,477Luis J. Montaner · Wistar Institute · R01 · FY2022 · DA
Biobehavioral Imaging and Molecular Neuropsychopharmacology of Substance Abuse Mechanisms
$1,651,729Michael Michaelides · National Institute On Drug Abuse · ZIA · FY2019 · DA
Southern Consortium Node of the Clinical Trials Network
$1,651,467Kathleen Theresa Brady · Medical University Of South Carolina · UG1 · FY2021 · DA
7/24 Healthy Brain and Child Development National Consortium
$1,650,630Heather E Volk · Johns Hopkins University · U01 · FY2023 · DA
Center the Neurobiological Investigation of Drug Abuse
$1,649,996Steven R Childers · Wake Forest University Health Sciences · P50 · FY2008 · DA
Endocannabinoid Targeting for Opioid Induced Respiratory Depression
$1,648,561Tally Marie Milnes · University Of Arizona · R01 · FY2022 · DA
Neurotoxicity in the adult rat following chronic exposure to methamphetamine
$1,648,459Jean Lud Cadet · National Institute On Drug Abuse · ZIA · FY2012 · DA